Cover Image

KIR-HLA class I combinations in JIA-associated uveitis

Saved in:

Bibliographic Details
Main Authors:	Parsa Miriam (Author), McCurdy Deborah K (Author), Woo Jennifer MP (Author), Presson Angela (Author), Rajalingam Raj (Author), Levinson Ralph (Author), Holland Gary (Author)
Format:	Book
Published:	BMC, 2012-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
by: Chrissy H Roberts, et al.
Published: (2014)

The impact of KIR/HLA genes on the risk of developing multibacillary leprosy.
by: Hugo Vicentin Alves, et al.
Published: (2019)

Features of the course and treatment of JIA-associated uveitis
by: M.V. Panchenko, et al.
Published: (2019)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
by: Alpigiani MG, et al.
Published: (2008)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
by: Bracaglia C, et al.
Published: (2008)

Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
by: Ivan Foeldvari, et al.
Published: (2019)

Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis
by: Baildam EM, et al.
Published: (2008)

Psychological Effects and Quality of Life in Parents and Children with Jia-Associated Uveitis
by: Silvana Guerriero, et al.
Published: (2022)

Correction to: Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
by: Ivan Foeldvari, et al.
Published: (2020)

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
by: Dehoorne J, et al.
Published: (2011)

Long Term Experience in Patients With JIA-Associated Uveitis in a Large Referral Center
by: Luca Marelli, et al.
Published: (2021)

Association of genetic variants of KIR2DL4 and its ligand HLA-G gene with HCV susceptibility and chronicity
by: Ze-pei FENG, et al.
Published: (2023)

Discovery, characterization and structure-activity relationships of an inhibitor of inward rectifier potassium (Kir) channels with preference for Kir2.3, Kir3.X and Kir7.1
by: Jerod S Denton
Published: (2011)

Genetic association of antinuclear antibodies with HLA in JIA patients: a Swedish cohort study
by: Raya Saleh, et al.
Published: (2024)

Ethnic differences in pediatric SLE early disease severity: a comparison between Hispanic-Americans and European-Americans
by: Liu Peony, et al.
Published: (2012)

Encouraging visual outcomes in children with idiopathic and JIA associated uveitis: a population-based study
by: Mira Siiskonen, et al.
Published: (2023)

Abatacept for severe anti-TNF-alfa refractory JIA-associated uveitis: one year follow-up
by: Traverso CE, et al.
Published: (2011)

Implementation of an electronic interface for the documentation of pediatric rheumatology medical records improves physician and patient utilization of time in clinic
by: Woo Jennifer MP, et al.
Published: (2012)

Otimização de metodologia para o estudo de genes KIR Methodology optimization for KIR genotyping
by: Cristiane Conceição Chagas Rudnick, et al.
Published: (2010)

Use of bromfenac 0.09% (Broksinak) in the complex therapy for HLA-B27-associated anterior uveitis
by: Oleksandra Zborovska
Published: (2024)

Plasma osteopontin as a marker for future organ damage in pediatric systemic lupus erythematosus
by: Rullo Ornella J, et al.
Published: (2012)

Jia Zhangke on Jia Zhangke
by: Berry, Michael
Published: (2022)

Jia Zhangke on Jia Zhangke
by: Berry, Michael
Published: (2022)

Influence of Interleukin IL-2 and IL-12 + IL-18 on Surface Expression of Immunoglobulin-Like Receptors KIR2DL1, KIR2DL2, and KIR3DL2 in Natural Killer Cells
by: Slawomir Chrul, et al.
Published: (2006)

Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
by: Ashley M. Cooper, et al.
Published: (2021)

Sildenafil affects the human Kir2.1 and Kir2.2 channels at clinically relevant concentrations: Inhibition potentiated by low Ba2+
by: Akimasa Iijima, et al.
Published: (2023)

Computational Identification of Novel Kir6 Channel Inhibitors
by: Xingyu Chen, et al.
Published: (2019)

Endocannabinoid regulation of inward rectifier potassium (Kir) channels
by: Sultan Mayar, et al.
Published: (2024)

Cell Based Treatment of Autoimmune Diseases in Children
by: Olcay Y. Jones, et al.
Published: (2022)

Quantificação de antígenos HLA classe I solúveis pela técnica de ELISA = Quantification of soluble HLA class I antigens by ELISA assay
by: Elisiane Coan Boian, et al.
Published: (2009)

Development of the paediatric society of the African league against rheumatism (PAFLAR) JIA registry and clinical profile of JIA in Africa from the PAFLAR JIA registry
by: Angela Nyangore Migowa, et al.
Published: (2024)

Where Does Art Come From?
by: McCurdy, Leah
Published: (2022)

HLA class II alleles in couples with failed ART attempts
by: A.N. Zagarskikh, et al.
Published: (2022)

Dynamic duo: Kir6 and SUR in KATP channel structure and function
by: Bruce L. Patton, et al.
Published: (2024)

Peculiarities of distribution of HLA class I antigens in patients with lihen planus
by: Irina I. Zakhur, et al.
Published: (2021)

HLA class II allele genetic propensity in Oral submucous fibrosis
by: Dr Bharathi M Purohit, et al.
Published: (2023)

HLA and skin cancer HLA e câncer de pele
by: Renan Rangel Bonamigo, et al.
Published: (2012)

KONTRIBUSI PERPUSTAKAAN SEKOLAH DALAM MENUNJANG KEGIATAN KELOMPOK ILMIAH REMAJA (KIR)
by: Santoso, Hari

A phenylalanine at the extracellular side of Kir1.1 facilitates potassium permeation
by: Henry Sackin, et al.
Published: (2024)

Potassium Channel KIR4.1-Specific Antibodies and Acquired Demyelinating Disease
by: J Gordon Millichap, et al.
Published: (2014)